2026-2034年全球治療性低溫療法系統市場規模、佔有率、趨勢和成長分析報告

預計治療性低溫療法系統的市場規模將從 2025 年的 3.4148 億美元成長到 2034 年的 5.4399 億美元，2026 年至 2034 年的複合年成長率為 5.31%。

由於對心臟麻痹、中風和創傷性腦損傷等疾病的先進醫療治療需求不斷成長，全球治療性低溫系統市場正在擴張。治療性低溫系統旨在以可控的方式降低患者體溫，從而保護大腦和其他重要器官免受損傷。醫院和醫療機構擴大將這些系統納入重症監護流程，這推動了市場成長。

市場促進因素之一是心血管和神經系統疾病發生率的上升。治療性低溫療法已被證實能有效提高心臟麻痹患者的存活率和神經系統預後。此外，包括表冷卻系統和血管內冷卻技術在內的冷卻設備的技術進步，正在提高治療的精確度和病人安全性。

未來幾年，由於醫療保健投資的增加和醫療技術的進步，預計市場將持續成長。正在進行的研究和臨床試驗正在探索低溫療法系統的新治療應用。隨著醫院不斷採用先進的重症監護設備並改善急救護理，治療性低溫療法系統的市場預計將在全球範圍內穩步擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球治療性低溫療法系統市場：依產品類型分類

• 市場分析、洞察與預測
• 冷卻裝置
• 冷卻導管
• 冰袋
• 其他

第5章 全球治療性低溫療法系統市場：依適應症分類

• 市場分析、洞察與預測
• 神經病學
• 循環系統
• 新生兒護理
• 其他

第6章 全球治療性低溫療法系統市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 專科診所
• 門診手術中心

第7章 全球治療性低溫療法系統市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Asahi Kasei Corporation
  • Audax Management Company LLC
  • Becton
  • Dickinson And Company
  • EM-MED Sp. Z Oo Sp. K
  • Gentherm Incorporated
  • International Biomedical Ltd
  • Phoenix Medical Systems Pvt. Ltd
  • Shenzhen Comen Medical Instruments Co. Ltd
  • Stryker Corporation
  • Terumo Corporation

The Therapeutic Hypothermia Systems Market size is expected to reach USD 543.99 Million in 2034 from USD 341.48 Million (2025) growing at a CAGR of 5.31% during 2026-2034.

The global therapeutic hypothermia systems market is expanding due to the growing demand for advanced medical treatments for cardiac arrest, stroke, and traumatic brain injuries. Therapeutic hypothermia systems are designed to lower a patient's body temperature in a controlled manner to protect the brain and other vital organs from damage. Hospitals and healthcare facilities are increasingly adopting these systems as part of critical care treatments, which is driving market growth.

One of the major drivers of the market is the rising prevalence of cardiovascular diseases and neurological disorders. Therapeutic hypothermia has proven effective in improving survival rates and neurological outcomes for patients after cardiac arrest. Additionally, technological advancements in cooling devices, including surface cooling systems and intravascular cooling technologies, are enhancing treatment precision and patient safety.

In the coming years, the market is expected to witness continued growth due to increasing healthcare investments and advancements in medical technologies. Ongoing research and clinical trials are exploring new therapeutic applications for hypothermia systems. As hospitals continue to adopt advanced critical care equipment and improve emergency response treatments, the therapeutic hypothermia systems market is likely to expand steadily worldwide.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Cooling Devices
• Cooling Catheters
• Cooling Packs
• Other

By Indication

• Neurology
• Cardiology
• Neonatal Care
• Other

By End-Use

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

COMPANIES PROFILED

• Asahi Kasei Corporation, Audax Management Company LLC, Becton, Dickinson and Company, EMMED Sp z oo Sp K, Gentherm Incorporated, International Biomedical Ltd, Phoenix Medical Systems Pvt Ltd, Shenzhen Comen Medical Instruments Co Ltd, Stryker Corporation, Terumo Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Cooling Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Cooling Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cooling Packs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: BY INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Indication
• 5.2. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Neonatal Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Indication
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Indication
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Indication
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Indication
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Indication
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Asahi Kasei Corporation
  • 9.2.2 Audax Management Company LLC
  • 9.2.3 Becton
  • 9.2.4 Dickinson And Company
  • 9.2.5 EM-MED Sp. Z O.o. Sp. K
  • 9.2.6 Gentherm Incorporated
  • 9.2.7 International Biomedical Ltd
  • 9.2.8 Phoenix Medical Systems Pvt. Ltd
  • 9.2.9 Shenzhen Comen Medical Instruments Co. Ltd
  • 9.2.10 Stryker Corporation
  • 9.2.11 Terumo Corporation